Remove Hospitals Remove Nurses Remove Virus
article thumbnail

Gut microbiome changes align with increased risk of type 2 diabetes

Broad Institute

Results of the study — which represents a collaboration across Brigham and Women’s Hospital, the Broad Institute of MIT and Harvard, and Harvard T.H. Co-first authors on the paper are Zhendong Mei of and Women’s Hospital and Broad, and Fenglei Wang of Harvard Chan School and Broad.

Virus 135
article thumbnail

NHS staff sign up to Covid-19 sniffer dog trial

The Pharma Data

Medical detection dogs Bramble (left) and Lexi during a visit to Kettering General Hospital. Eleven hospitals across the UK are taking part in the study, with scientists hoping at least 3,500 staff will provide “odour samples” Testing has begun to see if medical detection dogs can be trained to smell the disease.

Trials 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Coronavirus: NHS faces pandemic 'triple whammy' this winter

The Pharma Data

That money – announced over the summer – was intended to: help hospitals cope with the extra-infection control measures required. But hospitals are still performing only half the number of routine operations they normally would. It comes despite the government promising an extra £3bn this winter.

Nurses 52
article thumbnail

Eli Lilly’s Antibody Med Shows Potential in Preventing COVID-19 in the Elderly | 2021-01-21

The Pharma Data

Eli Lilly reported yesterday that its monoclonal antibody bamlanivimab (LY-CoV555) significantly lessened the risk of contracting COVID-19 among nursing home residents and staff, according to findings from a phase 3 trial. James Miessler. Source link.

Nurses 52
article thumbnail

New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19

The Pharma Data

(NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. “The investigational cocktail is now available to indicated high-risk U.S.

article thumbnail

RECOVERY Trial Data Monitoring Committee Recommends Continuing Evaluation of REGN-COV2 in All Hospitalized Patients

The Pharma Data

Regeneron announced today an update from the independent data monitoring committee (DMC) for the United Kingdom-based RECOVERY trial evaluating REGN-COV2 in hospitalized patients with COVID-19.

article thumbnail

mRNA vaccines slash risk of COVID-19 infection by 91% in fully vaccinated people

The Pharma Data

“We gave these vaccines to some of the highest risk groups in this country–doctors, nurses, and first responders,” Yoon says. “These are the people who are getting exposure to the virus day in and day out, and the vaccine protected them against getting the disease.

Vaccine 52